NICE has today (Tuesday 8 February 2022) issued draft guidance recommending semaglutide (also known as Wegovy and made by Novo Nordisk) to adults with at least one weight-related condition and a body mass index (BMI) of at least 35 kg/m2, ...
from Google Alert - health https://ift.tt/XC4BUfI
via IFTTT
0 comments:
Post a Comment